Razin DSR is a combination medication designed to provide effective relief from gastroesophageal reflux disease (GERD) and other gastrointestinal disorders. It contains Rabeprazole 20 mg and Domperidone (SR) 30 mg. Rabeprazole is a proton pump inhibitor (PPI) that works by reducing the production of stomach acid, thereby alleviating symptoms such as heartburn, difficulty swallowing, and persistent cough. It also helps in healing acid damage to the stomach and esophagus, preventing ulcers, and potentially reducing the risk of esophageal cancer.
Domperidone, in its sustained release (SR) form, is a dopamine D2 receptor antagonist that enhances gastrointestinal motility. This action helps in managing symptoms like bloating, nausea, and gastric discomfort by promoting the movement of food through the stomach and intestines. The SR formulation ensures a prolonged therapeutic effect, providing extended relief from symptoms. Together, Rabeprazole and Domperidone in Razin DSR work synergistically to offer comprehensive relief from GERD and related gastrointestinal issues, improving overall digestive health and patient comfort.